cjc-1295 + ipamorelin + aod-9604 1295 / (No DAC) 5mg, Ipamorelin 5mg (Blend) tesamorelin aod9604 + cjc1295 +
Description
Also useful for those with scarring alopecia or folliculitis-related thinning where tissue repair is a priority
An estimated timeline of results is: Weeks 46 shows a reduction in shedding Weeks 812 reveals new visible growth Months 36 show significant density improvements After 6 months continued gains are sustained with ongoing therapy Side Effects and Safety Considerations Peptide treatments are generally well-tolerated and have a favorable safety profile compared to traditional hair loss drugs
10.1371/JOURNAL.PONE.0104302 PLoS One
Apr 2011;33(2):138-43
When used together, the compounds appear to engage complementary biological pathways, providing a more comprehensive approach to structural and functional support at the tissue level
[DOI] [Google Scholar] 159.Fernandes G.D., Alberici R.M., Pereira G.G., Cabral E.C., Eberlin M.N., Barrera-Arellano D
